ArticleTranslational vision science & technology2025
Minimally Invasive Subretinal Perfluorocarbon Liquid (PFCL) Removal.
Article in Translational vision science & technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Perfluorocarbon liquid (PFCL) is widely used in retinal surgery; however, it can be complicated by subretinal retention that can affect/threaten fovea. A number of different approaches have been explored to remove retained PFCL. Here, we investigate the use of microneedles with internal diameters as small as 49 G. Methods: An in vitro model was used to examine the rate of aspiration of a fixed volume of 250 µL PFCL, whereby 30, 41, 43, and 49 gauge needles were examined. An ex vivo porcine model was then used to confirm whether subretinal PFCL could be consistently aspirated without blockage. Finally, this technique was used during pars plana vitrectomy (PPV) in 10 patients presenting with subfoveal or parafoveal retained PFCL. Results: Mean aspiration of 250 µL PFCL required 0.22, 0.33, and 0.78 minutes for the 30, 41, and 43 gauge needles at 200 mm Hg extraction pressure. Microneedle aspiration of 250 µL required maximal vacuum settings of 650 mm Hg to obtain a measurable average time to aspiration of 3.34 minutes. Ex vivo aspiration of subretinal PFCL required 400-650 mm Hg vacuum, where this was repeatable without any needle blockage. In 10 patients treated with PPV and microneedle subretinal PFCL aspiration, all cases were successful. Mean visual acuity change was of LogMAR -0.08 (±0.12). Conclusions: We recommend the clinical use of microneedles as a minimally invasive surgical option when considering direct retained PFCL removal. Translational Relevance: We confirmed the flow properties of microneedles for PFCL aspiration in vitro and ex vivo before successfully applying this to treat retained PFCL in patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.